Roivant Sciences (ROIV) Shares Repurchased (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Shares Repurchased for 5 consecutive years, with $208.3 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Shares Repurchased fell 67.88% year-over-year to $208.3 million, compared with a TTM value of $1.2 billion through Dec 2025, down 31.17%, and an annual FY2025 reading of $1.3 billion, changed N/A over the prior year.
  • Shares Repurchased was $208.3 million for Q2 2025 at Roivant Sciences, down from $997.8 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $997.8 million in Q4 2024 and bottomed at -$8.3 million in Q3 2022.
  • Average Shares Repurchased over 4 years is $245.6 million, with a median of $57.2 million recorded in 2022.
  • The sharpest move saw Shares Repurchased soared 205.3% in 2021, then tumbled 470.67% in 2022.
  • Year by year, Shares Repurchased stood at $2.2 million in 2021, then crashed by 470.67% to -$8.3 million in 2022, then skyrocketed by 12079.67% to $997.8 million in 2024, then crashed by 79.12% to $208.3 million in 2025.
  • Business Quant data shows Shares Repurchased for ROIV at $208.3 million in Q2 2025, $997.8 million in Q4 2024, and $106.1 million in Q3 2024.